연구동향 분석

A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments

배종우 최용성 정성훈 2017년

논문상세정보
    • 저자 배종우 최용성 정성훈
    • 제어번호 103611225
    • 학술지명 Yonsei medical journal
    • 권호사항 Vol. 58 No. 4 [ 2017 ]
    • 발행처 연세대학교의과대학
    • 발행처 URL http://www.eymj.org
    • 자료유형 학술저널
    • 수록면 823-828
    • 언어 English
    • 출판년도 2017
    • 등재정보 KCI등재
    • 소장기관 아주대학교 의학문헌정보센터
    • 판매처
    유사주제 논문( 0)
인용/피인용

' A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments' 의 참고문헌

  • 표면활성제 단백 Peptides 합성을 이용한 새로운 표면활성제의 표면 물리적특성에 관한 연구
    배종우 Korean Journal of Pediatrics 43 8 1059-1067 [2000]
  • Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials
    Moya F J Perinatol 29 Suppl 2 S23-S28 [2009]
  • Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits
    Almlén A Neonatology 98 91-99 [2010]
  • Synthesis, purification and surface activities of the human pulmonary surfactant protein-C (SP-C)analogue, SP-CL16 (6-28)
    Otsubo E Biol Pharm Bull 24 1362-1365 [2001]
  • Pulmonary surfactant: from molecular biology to clinical practice
    Robertson B 561-592 [1992]
  • Prediction of amyloid fibril-forming proteins
    Kallberg Y J Biol Chem 276 12945-12950 [2001]
  • One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials
    Moya F Pediatrics 119 e1361-e1370 [2007]
  • New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs
    Seehase M PLoS One 7 e47631- [2012]
  • Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome
    Soll RF Cochrane Database Syst Rev 2 CD000144- [2001]
  • Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome
    Soll R Cochrane Database Syst Rev 1 CD000141- [2009]
  • Membrane properties and amyloid fibril formation of lung surfactant protein C
    Johansson J Biochem Soc Trans 29 Pt 4 601-606 [2001]
  • KL4-surfactant (Lucinactant)protects human airway epithelium from hyperoxia
    Zhu Y Pediatr Res 64 154-158 [2008]
  • Injury and inflammation from resuscitation of the preterm infant
    Jobe AH Neonatology 94 190-196 [2008]
  • Hydrophobic surfactant proteins and their analogues
    Walther FJ Neonatology 91 303-310 [2007]
  • Effects of the human pulmonary surfactant protein-C (SP-C), SP-CL16 (6-28) on surface activities of surfactants with various phospholipids
    Otsubo E Biol Pharm Bull 25 1303-1306 [2002]
  • Early Prophylactic versus Late Selective Use of Surfactant for Respiratory Distress Syndrome in Very Preterm Infants: A Collaborative Study of 53 Multi-Center Trials in Korea
    김성미 Journal of Korean Medical Science 29 8 1126-1131 [2014]
  • Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties
    배종우 Yonsei Medical Journal 57 1 203-208 [2016]
  • Combined effects of polymers and KL(4)peptide on surface activity of pulmonary surfactant lipids
    Lu KW Biochim Biophys Acta 1798 1129-1134 [2010]
  • Changes in lung volume and ventilation during surfactant treatment in ventilated preterm infants
    Miedema M Am J Respir Crit Care Med 184 100-105 [2011]
  • Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis
    Nogee LM N Engl J Med 328 406-410 [1993]
  • Artificial surfactant therapy in hyaline-membrane disease
    Fujiwara T Lancet 1 55-59 [1980]
  • Animal derived surfactant extract for treatment of respiratory distress syndrome
    Seger N Cochrane Database Syst Rev 2 CD007836- [2009]